Dose Range Study of CD5789 in Acne Vulgaris
Clinical trial NCT01616654 · COMPLETED
Trial details
- NCT number
- NCT01616654
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-20
- Primary completion
- 2013-07-24
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.